An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165
Clinical trial NCT01819727 · COMPLETED
Trial details
- NCT number
- NCT01819727
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-11-25
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.